The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.
Guideline on Stability Testing for Active and Medicinal Products Manufactured in Climatic Zones III and IV to be Marketed in the EU - Explanatory Note on the Withdrawal of ICH Q1F
Short Title:
CPMP/ICH/421/02
Origin/Publisher:
EMEA
Document Type:
CPMP Guideline
Content:
The ICH guideline Q1F was intended to define the type and extent of stability studies required in those cases, where parts of the manufacture of the active substance or drug product were performed in climatic zone III and IV. In the meantime this guideline has been withdrawn.
GMP Conferences by Topics
- General Quality Assurance and GMP Compliance Topics
- Hygiene
- General Microbiology Topics
- Regulatory Affairs
- Development
- General Analytics Topics
- Good Distribution Practice
- Sterile Manufacturing
- Computer Validation
- General Qualification/Validation Topics
- General Engineering Topics
- APIs/Excipients
- GMP Basic Training Courses
- Medical Devices and Combination Products
- Packaging and Packaging Material
- Data Integrity
- Qualified Person (QP)
- GMP Auditing
- Documentation
- Cleaning Validation
- General IT Compliance Topics
- Impurities
- OOS / OOE / OOT
- Material Testing
- Validation of Analytical Methods
- Analytical Instrument Qualification
- Stability Testing
- Microbiological Testing
- Technology
- General Manufacturing Topics
- Solid Dosage Forms/Semi-Solid Dosage Forms
- Biotechnology/Blood/ATMP
- Herbal Drug Products/Cannabis/Radiopharmaceuticals
- Others